A genetically modified auxiliary graft transplant, implemented in a patient with the aim of improving his cardiac function, managed to function for a month. However, the procedure took a critical turn when serious complications arose, forcing the doctors to remove the graft. Despite exhaustive efforts to prolong the patient's life and to innovate the treatment, the situation progressively deteriorated.
Finally, the patient died 171 days after the initial transplant. This case highlights not only the advances in biotechnology applied to medicine, but also the persistent challenges and the risks associated with genetically modified organ transplants. The medical community continues to investigate and evaluate the results in order to improve future procedures and minimize complications in interventions of this kind.
Read the full news article on The World.
